Company intelligence / Profile preview

SmarterDx

New York, New York, United Statessmarterdx.com ↗

Ownership: Private
Development stage: Commercial

Overview

SmarterDx’s clinical AI platform reviews 100% of patient charts to identify missing or incorrect diagnoses, enabling hospitals to recover millions in earned revenue and improve care quality metrics. The solution delivers an average of $2 million in net new annual revenue per 10,000 patient discharges and boasts a 5x ROI with a KLAS client satisfaction score of 98. Used by over 30 health systems and more than 200 hospital sites across the U.S., the technology has demonstrated rapid adoption and high customer retention.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on SmarterDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmarterDx.

Explore the full profile